After the FDA issued an emergency use authorization (EUA) for a COVID-19 drug but limited its use to hospital inpatients, the association of American Physicians and Surgeons (AAPS) mounted a legal challenge. Did it prevail?
In a social media landscape shaped by hashtags, algorithms, and viral posts, nurse leaders must decide: Will they let the narrative spiral, or can they adapt and join the conversation?
...
